We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Sponsor content
356 result(s) found, displaying 261 to 270
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for GARDASIL 9 Human Papillomavirus 9-valent Vaccine, Recombinant, 30, 40, 60, 40, 20, 20, 20, 20, 20 micrograms / 0.5mL, suspension for injection, vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for GARDASIL 9 Human Papillomavirus 9-valent Vaccine, Recombinant, 30, 40, 60, 40, 20, 20, 20, 20, 20 micrograms/0.5mL, suspension for injection, syringe.
-
Designation or determinationProvisional approval
-
Designation or determinationPriority review
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Pembrolizumab [Keytruda]
-
Prescription medicine registrationActive ingredients: letermovir.
-
Prescription medicine registrationActive ingredients: pembrolizumab.
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd